Skip to main content
Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

CMLT20003, Moore, NRG-GY022, Malignant Solid Neoplasm, Carboplatin

Research Question:
How well does iohexol, a contrast agent, work in helping doctors calculate the dose of carboplatin given to patients with cancer?

Basic Study Information

Purpose:
This trial studies how well iohexol works in helping doctors calculate the dose of carboplatin given to patients with cancer. Drugs used in chemotherapy, such as carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Understanding how to best calculate the dose of carboplatin given to patients with cancer may help doctors learn how to improve the use of carboplatin in the future.

Location: University of Rochester Medical Center
Study Reference #: CMLT20003

Lead Researcher (Principal Investigator)

Lead Researcher:  Richard Moore

Study Contact Information

Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu

Additional Study Details

Return to Search